Glyxambi (empagliflozin and linagliptin) tablets

Glyxambi (empagliflozin and linagliptin) tablets

Company:  Boehringer Ingelheim Pharmaceuticals, Inc.
Application No.:  206073
Approval Date: 01/30/2015

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.

 

Date created: April 11, 2016

Back to Top    Drugs@FDA

Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English